Filter
1184
Filtered Results: 1184
Text search:
rifampicin
Featured
Recommendations
139
New Publications
297
Language
Document type
No document type
748
Guidelines
179
Studies & Reports
109
Manuals
65
Strategic & Response Plan
31
Training Material
20
Fact sheets
20
Situation Updates
6
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
India
61
Western and Central Europe
60
Eastern Europe
36
South Africa
28
Nepal
27
Latin America and the Carribbean
22
Kenya
21
Argentina
19
Global
18
Colombia
16
Nigeria
16
Tanzania
16
Peru
15
Paraguay
14
Uganda
14
Namibia
14
Ethiopia
14
Zambia
14
Germany
13
Bangladesh
13
Indonesia
13
Rwanda
12
Malawi
12
El Salvador
11
Senegal
11
Myanmar / Burma
11
Ukraine
10
Philippines
10
Bolivia
10
Brazil
10
South–East Asia Region
9
Mozambique
8
Cambodia
8
Asia
8
Congo, Democratic Republic of
8
Cameroon
7
Russia
7
Africa
6
Tajikistan
5
Benin
5
Zimbabwe
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Ghana
4
Chile
4
Burkina Faso
4
Venezuela
4
Botswana
4
Liberia
4
Madagascar
4
Lesotho
3
Haiti
3
Georgia
3
Bhutan
3
Pakistan
3
Timor Leste/ East Timor
2
Sierra Leone
2
Syria
2
Armenia
2
Jordan
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Central African Republic
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Guinea
1
USA
1
Dominican Republic
1
Saudi Arabia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Turkmenistan
1
France
1
Tunisia
1
Spain
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Mali
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
464
Clinical Guidelines
146
Women & Child Health
25
Public Health
23
Capacity Building
16
Pharmacy & Technologies
14
Key Resources
9
Toolboxes
TB
540
HIV
107
NTDs
69
AMR
44
Pharmacy
42
Refugee
18
Polio
13
COVID-19
9
Ebola & Marburg
8
Caregiver
6
Mental Health
5
Conflict
5
Rapid Response
3
Global Health Education
3
Natural Hazards
2
Planetary Health
1
Health Financing Toolbox
1
NCDs
1
Malaria
1
Zika
1
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional de In...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
La publicación describe el método aplicado en los laboratorios que han realizado la validación, como un método rápido de tamizaje para la detección de resistencia a isoniacida y rifampicina en muestras de esputo de pacientes con tuberculosis pulmonar que aún no hayan iniciado tratamiento anti...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequency of M. tuberculosis strains that were resistant...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
Technical and operational ‘how-to’: practical considerations
Consenso de los Laboratorios Supranacionales (LSN), Centros Colaboradores (CC) y Laboratorios Nacionales de Referencia (LNR) de “países priorizados” para la aplicación del Xpert-MTB/Rif en Las Américas.
Guatemala, 11-12 abril de 2011
Accessed December 2017
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
Journal of Infectious Diseases and Therapeutics, 2013, 1, 17-24
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
